Norethindrone-d6

CAT: 0804-HY-B0554S-01Size: 1 mgDry Ice: NoHazardous: No
CAT#:0804-HY-B0554S-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Norethindrone-d6 is the deuterium labeled Norethindrone. Norethindrone is a female progestin approved by FDA for the treatment of endometriosis, uterine bleeding caused by abnormal hormone levels, and secondary amenorrhea. Norethindrone-d6 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
CAS Number
[2376036-05-2]
UNSPSC
12352211
Hazard Statement
H302, H315, H319, H335
Target
Isotope-Labeled Compounds; Progesterone Receptor
Type
Isotope-Labeled Compounds
Related Pathways
Others; Vitamin D Related/Nuclear Receptor
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Endocrinology
Purity
99.88
Solubility
10 mM in DMSO
Smiles
C[C@@]12[C@](CC[C@@]2(O)C#C)([H])[C@@]3([H])[C@]([C@]4([2H])C(C([2H])([2H])C3)=C([2H])C(C([2H])([2H])C4)=O)([H])CC1
Molecular Formula
C20H20D6O2
Molecular Weight
304.46
Precautions
H302, H315, H319, H335
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Cheng DC, et al. Norethindrone acetate inhibition of triglyceride synthesis and release by rat hepatocytes. Atherosclerosis. 1983 Jan;46 (1) :41-8.|[3]Kaser DJ, et al. Use of norethindrone acetate alone for postoperative suppression of endometriosis symptoms. J Pediatr Adolesc Gynecol. 2012 Apr;25 (2) :105-8.|[4]Maier WE, et al. Pharmacology and toxicology of ethinyl estradiol and norethindrone acetate in experimental animals. Regul Toxicol Pharmacol. 2001 Aug;34 (1) :53-61.|[5]Muneyyirci-Delale O, et al. Effect of norethindrone acetate in the treatment of symptomatic endometriosis. Int J Fertil Womens Med. 1998 Jan-Feb;43 (1) :24-7.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported

Related Products

CatalogName
HY-W654295Norethindrone-2,2,4,6,6,10-d6
HY-B0554-01Norethindrone
HY-W748961Norethindrone Acetate-2,2,4,6,6,10-d6
HY-B0554S2Norethindrone-d8
HY-B0554R-01Norethindrone (Standard)
HY-B1710-01Norethindrone acetate
HY-W746582Norethindrone-d7
HY-B0554S1Norethindrone-13C2
HY-B1710R-01Norethindrone acetate (Standard)
HY-B1710SNorethindrone acetate-d8

Alternative Products

CatalogName
ESS0059-01Norethindrone-D6 (major)
ESS0060-01Norethindrone Acetate-D6 (major)
TRC-N676002-25MGNorethindrone-2,2,4,6,6,10-d6
TRC-N676000-100MGNorethindrone
MF-0102117-01Norethindrone Acetate-2,2,4,6,6,10-d6
BUP16754-01Norethindrone acetate

Popular Products